(Q37071155)

18 August 2017

1 reference

title

Vaccines for Chlamydia infections of the female genital tract (English)

1 reference

18 August 2017

Louise M Hafner

1

1 reference

18 August 2017

Celia McNeilly

series ordinal

2

1 reference

18 August 2017

language of work or name

1 reference

1 February 2008

1 reference

18 August 2017

number of pages

11

1 reference

based on heuristic

inferred from page(s)

published in

Future Microbiology

1 reference

18 August 2017

volume

3

1 reference

18 August 2017

issue

1

1 reference

18 August 2017

page(s)

67-77

1 reference

Chlamydia trachomatis infections: progress and problems

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.67

Opportunistic screening for genital chlamydial infection. II: prevalence among healthcare attenders, outcome, and evaluation of positive cases

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.67

Sexually Transmitted Diseases Among American Youth: Incidence and Prevalence Estimates, 2000

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.67

Clinical practice. Genital chlamydial infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.67

Chlamydia trachomatis: impact on human reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.67

Chlamydia trachomatis infection as a risk factor for invasive cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.67

Association of Chlamydia trachomatis with persistence of high-risk types of human papillomavirus in a cohort of female adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.67

Cofactors in male-female sexual transmission of human immunodeficiency virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.67

The chlamydial developmental cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.67

Interaction of Chlamydia trachomatis with mammalian cells is independent of host cell surface heparan sulfate glycosaminoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.67

The Chlamydia trachomatis IncA protein is required for homotypic vesicle fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.67

Intracellular survival by Chlamydia

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.67

Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.67

Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein by use of CpG oligodeoxynucleotides as an adjuvant induces a protective immune response against an intranasal chlamydial challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.67

Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.67

Vaccination with the Chlamydia trachomatis major outer membrane protein can elicit an immune response as protective as that resulting from inoculation with live bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.67

Human phase I vaccine trials of 3 recombinant asexual stage malaria antigens with Montanide ISA720 adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.67

CpG oligodeoxynucleotide enhances immunity against blood-stage malaria infection in mice parenterally immunized with a yeast-expressed 19 kDa carboxyl-terminal fragment of Plasmodium yoelii merozoite surface protein-1 (MSP1(19)) formulated in oil-ba

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.67

The anti-idiotypic antibody to chlamydial glycolipid exoantigen (GLXA) protects mice against genital infection with a human biovar of Chlamydia trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.67

Immune response to the Chlamydia trachomatis outer membrane protein PorB.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.67

Identification of new potential vaccine candidates against Chlamydia pneumoniae by multiple screenings.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.67

Intranasal immunization with chlamydial protease-like activity factor and CpG deoxynucleotides enhances protective immunity against genital Chlamydia muridarum infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.67

Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.67

Expression library immunization confers partial protection against Chlamydia muridarum genital infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.67

Monitoring the T cell response to genital tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.67

Collaborative multidisciplinary workshop report: progress toward a Chlamydia pneumoniae vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.67

Comparative genomes of Chlamydia pneumoniae and C. trachomatis

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.67

A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.67

Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F17460913.3.1.67

21 January 2018

Identifiers

DOI

10.2217/17460913.3.1.67

1 reference

18 August 2017

1 reference